Sean Doyle Email Address

Associate Director

Achaogen, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of antibacterials to treat multi-drug resistant (MDR) gram-negative infections. The Company is developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections due to MDR Enterobacteriaceae, including carbapenem-resistant enterobacteriaceae (CRE). Plazomicin is an aminoglycoside designed to overcome clinically relevant aminoglycoside resistance mechanisms. In addition, its research and development pipeline includes two programs that specifically target Pseudomonas aeruginosa or Acinetobacter baumannii infections: a program to discover and develop small molecule inhibitors of LpxC, which is an enzyme essential for the synthesis of the outer membrane of gram-negative bacteria, and a therapeutic antibody program. Its development plan for plazomicin includes over two Phase III clinical trials.

IT professional with a history of achieving organizational objectives, cost savings and enhancing system functionality. Track record of tackling and solving business and technical problems. Strong leader with demonstrated ability to work effectively with individuals at all levels and in all functional areas. Specialties:-Team management experience in a fast paced IT environment -Planning and implementing operational excellence measures -Strategic IT and business planning -Creating processes to meet Service Level Agreements -Exceptional customer service skills -Strong written and verbal communications skills -Highly organized with strong analytical and presentation abilities